These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8508266)

  • 1. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.
    van Leeuwen MA; van Rijswijk MH; van der Heijde DM; Te Meerman GJ; van Riel PL; Houtman PM; van De Putte LB; Limburg PC
    Br J Rheumatol; 1993 Jun; 32 Suppl 3():9-13. PubMed ID: 8508266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression.
    Stenger AA; Van Leeuwen MA; Houtman PM; Bruyn GA; Speerstra F; Barendsen BC; Velthuysen E; van Rijswijk MH
    Br J Rheumatol; 1998 Nov; 37(11):1157-63. PubMed ID: 9851262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
    van Leeuwen MA; van Rijswijk MH; Sluiter WJ; van Riel PL; Kuper IH; van de Putte LB; Pepys MB; Limburg PC
    J Rheumatol; 1997 Jan; 24(1):20-7. PubMed ID: 9002006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.
    van Leeuwen MA; Westra J; Limburg PC; van Riel PL; van Rijswijk MH
    Ann Rheum Dis; 1995 Aug; 54(8):674-7. PubMed ID: 7677445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
    Jansen LM; van der Horst-Bruinsma IE; van Schaardenburg D; Bezemer PD; Dijkmans BA
    Ann Rheum Dis; 2001 Oct; 60(10):924-7. PubMed ID: 11557647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
    Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
    Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
    Carrier N; Marotta A; de Brum-Fernandes AJ; Liang P; Masetto A; Ménard HA; Maksymowych WP; Boire G
    Arthritis Res Ther; 2016 Feb; 18():37. PubMed ID: 26832367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
    Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
    Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.
    Markatseli TE; Voulgari PV; Alamanos Y; Drosos AA
    J Rheumatol; 2011 Jan; 38(1):44-52. PubMed ID: 20952476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.
    Vittecoq O; Pouplin S; Krzanowska K; Jouen-Beades F; Menard JF; Gayet A; Daragon A; Tron F; Le Loet X
    Rheumatology (Oxford); 2003 Aug; 42(8):939-46. PubMed ID: 12730503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between body mass index and radiological progression in patients with rheumatoid arthritis.
    Kaufmann J; Kielstein V; Kilian S; Stein G; Hein G
    J Rheumatol; 2003 Nov; 30(11):2350-5. PubMed ID: 14677176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
    van Leeuwen MA; van der Heijde DM; van Rijswijk MH; Houtman PM; van Riel PL; van de Putte LB; Limburg PC
    J Rheumatol; 1994 Mar; 21(3):425-9. PubMed ID: 7516430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
    Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M;
    Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of intra-articular injections into the temporomandibular joint in patients with rheumatoid arthritis.
    Vallon D; Akerman S; Nilner M; Petersson A
    Swed Dent J; 2002; 26(4):149-58. PubMed ID: 12611144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis.
    Cheung NT; Dawes PT; Poulton KV; Ollier WE; Taylor DJ; Mattey DL
    J Rheumatol; 2000 Apr; 27(4):882-7. PubMed ID: 10782810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.